DVx Prices Lot Friction, Not the Ratio

Summary: DVx (3079.T) shareholders are scheduled to receive 0.50 shares of Olba Healthcare (2689.T) for each DVx share on September 1, 2026, subject to shareholder approval. At the last full common session on May 22, 2026, DVx closed at JPY 998 while Olba closed at JPY 2,068, implying JPY 1,034 of exchange value and a JPY 36, or 3.61%, discount. Even after the gap tightened, delayed intraday quotes checked on May 25, 2026 still showed DVx at JPY 1,004 at 12:24 Singapore time and Olba at JPY 2,040 at 11:53 Singapore time, leaving an implied value of JPY 1,020 and a live discount of about JPY 16, or 1.59%. The remaining gap looks more like odd-lot and liquidity friction than broken deal math. [1][2][3]

Opportunity Ranking

Rank	Idea	Discovery Lane	Why It May Be Best Now	Evidence Freshness	Catalyst Window	Asymmetry	Main Reason to Reject
1	DVx prices lot friction, not the ratio	Japan small-cap / stock-for-stock merger mechanics	The official exchange ratio is 1 DVx : 0.50 Olba, the effective date is fixed for September 1, and the live gap still exists even after the initial compression. The likely reason is mechanical: holders below 200 DVx shares risk receiving less than one round lot of Olba. [1][2][3]	Official contract dated May 22, 2026 plus live delayed quotes checked in this run. [1][2][3]	DVx vote June 26, Olba vote July 28, DVx last trading day August 27, delisting August 28, effective date September 1. [1]	Moderate gross spread, cleaner timing than court-sale squeeze-outs, and a tradable hedge if Olba borrow is available.	Absolute edge is small and requires discipline on borrow, fees, and liquidity.
2	Wave Lock prices court lag and vote risk	Japan small-cap / squeeze-out mechanics	Wave Lock trades at JPY 1,048 against a stated JPY 1,070 cash-out value. [4][5]	Official filing dated May 20, 2026 plus live delayed quote checked in this run. [4][5]	Vote on June 18, delisting on July 9, but company guidance points to court petition in late July and cash delivery only around mid-to-late October. [4]	The gross spread is visible, but the capital is tied up far longer than the delisting date suggests.	Only 38.55% of shares are already aligned to vote yes, and the payment tail is long. [4]
3	G-Foot's approved squeeze-out is cleaner but thinner	Japan low-price / approved squeeze-out	G-Foot already won shareholder approval and still trades at JPY 296 against a JPY 300 per-share cash value. [6][7]	Official approval filing dated May 22, 2026 plus live delayed quote checked in this run. [6][7]	Delisting on June 23, with later court-process execution for the fractional-share sale. [6]	Clean approval status, but only a small remaining spread.	Too little gross spread for the remaining timing uncertainty.
4	KPF's cancellation story is real, but the rerating path is slower	Korea small-cap / capital return	KPF last printed KRW 5,720 on the May 22, 2026 Korea close, with a market cap of about KRW 115.3 billion and a new KRW 1 billion buyback-and-cancel program running through June 19 with cancellation scheduled for June 29. [8][9][10]	Korean quote and shareholder-return reporting checked in this run. [8][9][10]	Buyback window through June 19, cancellation scheduled for June 29. [9][10]	Meaningful if the market finally prices the shrinking denominator.	The payoff depends on a broader rerating, not a hard closing ratio.

Selected opportunity: DVx vs Olba exchange-ratio spread.

Why this one now: It combines live evidence, a dated close, a mechanical source of friction, and a cleaner settlement path than the Japanese cash squeeze-outs still stuck behind court-sale timing.

What should surprise the reader: A board-approved 0.50 stock-for-stock ratio can still leave a small-cap target below parity because the nuisance is not valuation. It is lot size.

Geographic Search Audit

Scope override: The user explicitly limited this run to Japan and Korea.
Japan candidate screened, compliant with the <= JPY 800 bias: G-Foot (2686.T) at JPY 296. Rejected because the gross spread is only JPY 4 and the cash path still depends on later court processing. [6][7]
Japan candidate screened, higher-price override: Wave Lock (7940.T) at JPY 1,048. Rejected because the company itself guides the cash-delivery path out to roughly October, and only 38.55% of shares are already aligned to vote yes. [4][5]
Broader Asia candidate screened: KPF (024880.KQ) at KRW 5,720 on the May 22, 2026 Korea close. Rejected because the shareholder-return thesis is real but slower and less mechanical. [8][9][10]

Japan Lane Override Note

DVx trades above the repo's default Japan price preference at JPY 1,004. The override is still justified.

The best compliant Japanese candidate I found under JPY 800 was G-Foot at JPY 296, but that spread is only 1.35% to the stated JPY 300 cash value and still runs through a post-delisting court-sale process. Wave Lock offers a larger gross spread, but its own filing points to a court petition in late July and shareholder cash delivery only around mid-to-late October, while disclosed aligned votes amount to just 38.55%. DVx is less cheap on sticker price, but the closing path is better: listed stock consideration, no fractional-share court sale for holders who size correctly, and an effective date fixed for September 1, 2026. [1][4][6]

Why This Is the Best Opportunity Right Now

This is not a grand valuation call. It is a settlement-mechanics call.

On May 22, 2026, Olba and DVx signed a stock-exchange contract under which each DVx share will be exchanged for 0.50 Olba shares. DVx shareholders vote on June 26. Olba shareholders vote on July 28. DVx is scheduled to stop trading on August 27, delist on August 28, and the exchange is scheduled to take effect on September 1. [1]

That is already enough to create a price anchor. But the market still is not using it cleanly.

At the last full common session before this run, DVx closed at JPY 998 while Olba closed at JPY 2,068. That put implied value at JPY 1,034, a JPY 36 gap. [2][3] On the delayed intraday feed checked on May 25, the discount had narrowed, but it had not disappeared. [2][3]

The key point is that the remaining wedge does not look like the market pricing a busted deal. It looks like the market pricing nuisance.

What Should Surprise the Reader

The surprise is not the ratio itself. The ratio is public.

The surprise is the lot-size trap hiding underneath it.

DVx's filing explicitly states that holders with fewer than 200 DVx shares will receive fewer than 100 Olba shares, which means they risk ending up with less than one standard trading lot after the exchange. Those odd-lot holders cannot simply dump the resulting position on-exchange in the ordinary way. [1]

That matters because DVx is small and thin. The market cap is about JPY 10.9 billion, issued shares are 10.78 million, and the delayed intraday quote page showed only 4,500 shares of volume when checked. [2] Olba is larger, but still not especially liquid, with a market cap of about JPY 12.8 billion, issued shares of 6.25 million, and just 8,800 shares of intraday volume on the same delayed feed. [3]

The market is not ignoring the ratio. It is charging a friction tax for dealing with it.

The Setup

DVx distributes medical devices and products. Olba is a healthcare distribution and services group. Their announced integration is conventional. The trade is not.

The trade exists because the consideration is listed stock rather than cash, and because the target's shareholder base includes investors for whom the post-exchange lot outcome matters as much as the headline ratio.

In a clean world, a stock-for-stock exchange with a public fixed ratio should make the target behave like a shadow of the acquirer. In the real world, small-lot holders, thin order books, delayed quotes, and imperfect hedge access can leave the target below fair exchange value for weeks.

That is the opening.

The Market Price

Market Level	Value	Timestamp / Source	Why It Matters
DVx live delayed quote	JPY 1,004	Kabutan quote page, checked at 2026-05-25 12:24 Singapore time [2]	Current long leg reference.
Olba live delayed quote	JPY 2,040	Kabutan quote page, checked at 2026-05-25 11:53 Singapore time [3]	Current hedge leg reference.
Implied DVx value at the live ratio snapshot	JPY 1,020	Calculation: `0.50 x 2,040` [3]	Shows the spread is still open even after narrowing.
Live implied discount	JPY 16, or about 1.59%	Calculation from the live delayed quotes above	The edge available at the time of writing.
DVx prior close	JPY 998	Kabutan quote page, 2026-05-22 [2]	Last full common-session close.
Olba prior close	JPY 2,068	Kabutan quote page, 2026-05-22 [3]	Same-session acquirer close.
Implied DVx value at the May 22 close	JPY 1,034	Calculation: `0.50 x 2,068` [3]	Cleaner same-session parity reference.
May 22 closing discount	JPY 36, or 3.61%	Calculation from the May 22 closes above	Shows the spread was wider before the Monday narrowing.
DVx market cap / issued shares	JPY 10.9 billion / 10.78 million shares	Kabutan [2]	Confirms this is a small-cap, thin-liquidity setup.
Olba market cap / issued shares	JPY 12.8 billion / 6.25 million shares	Kabutan [3]	The hedge leg is bigger, but not deep enough to ignore execution.

The Positioning

I did not verify live stock-loan fee, rebate, or borrow availability for Olba during this run.

That missing-data note matters because the cleanest expression is a hedged common-stock pair. If borrow is unavailable or punitive, the trade deteriorates into a noisier long-only position in DVx.

What I can verify is the structural holder problem. DVx told shareholders that fewer than 200 DVx shares can translate into fewer than 100 Olba shares after applying the 0.50 ratio. [1] That is a real odd-lot penalty. It discourages some target holders from waiting for settlement and reduces the pool of natural arbitrage buyers to investors who can size deliberately and manage the hedge.

This is not classic crowded positioning. It is fragmented positioning.

The Catalyst

This trade has a dated path.

DVx shareholder approval is scheduled for June 26, 2026. [1]
Olba shareholder approval is scheduled for July 28, 2026. [1]
DVx's last trading day is scheduled for August 27, 2026. [1]
DVx is scheduled to delist on August 28, 2026. [1]
The share exchange is scheduled to take effect on September 1, 2026. [1]

Unlike the Japanese squeeze-out names screened in this run, this is not a court-sale cash path. The consideration is listed stock, and the effective date is explicit.

The Gap

The market seems to be pricing three things at once:

odd-lot nuisance for small holders
thin liquidity in both legs
and the possibility that approval or execution wobbles even though the agreement is already signed

The first point is real. The second point is real. The third point matters, but probably less than the current discount implies.

The cleaner comparison is against the Japanese squeeze-outs screened here. Wave Lock and G-Foot both offer stated cash values, but both still require post-delisting court handling to turn fractions into shareholder cash, and Wave Lock's own filing points to cash delivery only around October. [4][6] DVx instead converts into listed Olba shares on a fixed September effective date.

That settlement path is why DVx beats the cash-door alternatives despite the smaller sticker spread.

The Payoff Map

The cleanest expression is long DVx and short 0.50x Olba, subject to borrow availability and workable execution.

Long-only DVx is the fallback, not the first choice. The thesis is about the ratio gap, not a standalone bullish view on healthcare distribution.

Price Target and Probability Map

Scenario	Probability	Target / Level	Return / Payoff	Time Horizon	Conditions Required	Evidence Quality
Top Case	45%	DVx trades at full parity to 0.50x Olba	+JPY 16 per DVx share, or about +1.59% on the current live spread	1-3 months	Approvals stay on track, Olba borrow is available, and the lot-friction discount fully closes by the effective date	High
Base Case	35%	Gap narrows from JPY 16 to about JPY 8	+JPY 8 per DVx share, or about +0.80% on the current live spread	1-2 months	The market prices part, but not all, of the remaining nuisance discount	Medium
Bottom Case	20%	Gap widens to roughly JPY 35	-JPY 19 per DVx share, or about -1.89% from the current live spread	1-3 months	Borrow is poor, approvals look less certain, or the market demands more compensation for thin liquidity	Medium
Invalidation / Stop Condition	n/a	Ratio amended, approvals fail, or the hedge is unavailable at acceptable cost	n/a	n/a	The trade only works if the fixed-ratio path remains intact and executable	High

Probability-weighted expected value: about JPY 8.2 per DVx share, or roughly 0.82% on the current live spread, before borrow, commissions, and slippage.

Current market price / level: DVx JPY 1,004 vs Olba JPY 2,040 on delayed intraday feeds checked in this run. [2][3]

Timestamp: 2026-05-25 12:24 Singapore time for DVx and 2026-05-25 11:53 Singapore time for Olba. [2][3]

Primary instrument: DVx common stock, ideally paired against a 0.50x short in Olba common stock.

Alternative expressions considered: Long-only DVx common stock and Japanese squeeze-out cash spreads in Wave Lock and G-Foot. Long-only DVx was rejected as the primary expression because it inherits Olba beta. The squeeze-outs were rejected because their cash path is slower and more court-process dependent. [4][6]

Confidence: Medium.

What Could Go Wrong

The strongest counterargument is obvious. This spread is not free money because the gross edge is small and the friction is real.

The main failure modes are:

Olba borrow is unavailable or uneconomic
liquidity in one or both legs is too thin to enter cleanly
approvals or schedule dates move
or the market is correctly charging a larger nuisance discount than I think

There is also a more subtle risk. A long-only reader can look at the ratio math and think the trade is simply to buy DVx. That is a category error. The spread is the edge. The direction is secondary.

What Would Prove This Wrong

This thesis fails if:

the ratio is amended
either shareholder vote becomes meaningfully uncertain
Olba borrow cannot be sourced at workable economics
or the spread widens beyond roughly JPY 40 without a compensating change in Olba's price that preserves the ratio logic

For long-only holders, the bar is stricter. If you cannot isolate the ratio, you no longer own a clean mispricing trade.

Bottom Line

DVx is not a heroic Japan small-cap rerating story. It is a modest, mechanical spread with a real closing calendar and a real source of friction.

That is exactly why it is interesting.

The market has already narrowed the gap from the May 22 close, but the wedge has not disappeared. The official contract still says 0.50 Olba shares for each DVx share. The live delayed quotes checked in this run still showed DVx below that value. [1][2][3]

Best trade strategy: Long DVx common stock, preferably hedged with a short in 0.50x Olba common stock. No options-first structure here.

Sources

[1] Olba Healthcare and DVx stock-exchange contract, May 22, 2026

[2] Kabutan quote page for DVx (3079)

[3] Kabutan quote page for Olba Healthcare (2689)

[4] Wave Lock Holdings share-consolidation notice, May 20, 2026

[5] Kabutan quote page for Wave Lock Holdings (7940)

[6] G-Foot approval of share consolidation, May 22, 2026

[7] Kabutan quote page for G-Foot (2686)

[8] Naver Finance quote page for KPF (024880)

[9] KPF buyback-and-cancellation report, MoneyToday, May 21, 2026

[10] KPF buyback-and-cancellation report, Asiae, May 20, 2026

Research Quality Scorecard

Criterion	Score	Note
Market disagreement	4	The ratio is explicit, but the target still trades below implied value because of lot-size and liquidity friction.
Evidence base	5	The key terms, dates, and lot mechanics come from the official contract, with live quote checks in this run.
Positioning and flows	3	The odd-lot problem is well evidenced, but live borrow and full holder-base data were not verified.
Catalyst path	5	The votes, delisting date, and effective date are all scheduled.
Payoff architecture	4	The pair trade is defined, but the absolute edge is modest and costs matter.
Invalidation discipline	4	The trade clearly fails on ratio changes, vote trouble, or unusable hedge economics.
Differentiated insight	4	The useful insight is the lot-friction discount, not the headline merger announcement.
Client value	4	Even if the reader skips the trade, the note explains how small-cap stock-for-stock mechanics can stay mispriced.
Total	33/40	Publishable as a disciplined, mechanics-first trade note rather than a heroic conviction long.

AI Illustration Prompt

A realistic, high-value, high-end editorial cover image for a financial research note about a Japanese stock-for-stock merger spread caused by odd-lot friction. Composition: two crisp paper stock certificates or digital order tickets on a clean trading desk, one labeled "DVx" and the other "Olba", with a precise 1-to-0.5 exchange diagram floating between them. In the foreground, a neat stack of 199 small share chips stops just short of becoming a full 100-share Olba lot, visually dramatizing the odd-lot problem. Use restrained Tokyo market cues: muted exchange board glow, hospital-supply carton textures, thin green surgical packaging, and a polished steel ruler measuring the gap between the two securities. Color palette: off-white paper, charcoal, muted medical green, pale exchange-blue highlights, and a small band of warning red where the lot-size mismatch appears. Mood: analytical, quiet tension, precise rather than dramatic. Style: realistic, premium editorial photography or hyper-real illustration suitable for Bloomberg Markets, Barron's, or The Economist. Include a subtle but clear watermark or text treatment reading "The Mispricing Desk".